Everyday Health Inc (NYSE:EVDY) has been downgraded to Hold in a statement by Zacks Investment Research earlier today.
- Updated: October 4, 2016
Having a price of $7.96, Everyday Health Inc (NYSE:EVDY) traded 2.43% higher on the day. With the last close up 13.99% from the two hundred day average, compared with the S&P 500 Index which has decreased -0.01% over the same period. Everyday Health Inc has recorded a 50-day average of $7.59 and a two hundred day average of $7.04. Volume of trade was down over the average, with 150,528 shares of EVDY changing hands under the typical 169,449
Zacks Investment Research has downgraded Everyday Health Inc (NYSE:EVDY) to Hold in a statement released on 10/04/2016.
On Wednesday August 24, 2016, Zacks Investment Research released a statement on Everyday Health Inc (NYSE:EVDY) upped the target price from $0.00 to $8.50 that suggested an upside of 0.15%.
With a total market value of $0, Everyday Health Inc has with a one year low of $3.71 and a one year high of $10.59 .
A total of 6 analysts have released a research note on Everyday Health Inc. Three analysts rating the company a strong buy, three analysts rating the company a buy, zero analysts rating the company a hold, zero analysts rating the company a underperform, and finally zero analysts rating the company a sell with a 12-month price target of $12.50.
More About Everyday Health Inc (NYSE:EVDY)
Everyday Health, Inc., formerly Waterfront Media Inc., operates a digital marketing and communications platform for healthcare marketers that want to engage with consumers and healthcare professionals. The Company's platform combines content from brands, data and analytics. The Company's segment is providing digital health marketing and communications solutions. The Company's flagship brand, Everyday Health, is a health information portal that provides consumers with actionable health information intended to empower users to manage their health and wellness. The Company's flagship professional property, MedPage Today, includes a team of approximately 30 journalists, including editors, reporters and videographers, and provides clinical news based on research findings published in peer-reviewed medical journals, as well as research reported at various medical conferences around the world.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.